Yahiaoui Samir, Pouget Christelle, Fagnere Catherine, Champavier Yves, Habrioux Gérard, Chulia Albert José
UPRES EA 1085 Biomolécules et Cibles Cellulaires Tumorales, Faculté de Pharmacie, 2 rue du Docteur Marcland, 87025 Limoges, France.
Bioorg Med Chem Lett. 2004 Oct 18;14(20):5215-8. doi: 10.1016/j.bmcl.2004.07.090.
Aromatase is a target of pharmacological interest for the treatment of estrogen-dependent cancers. Azole derivatives such as letrozole or anastrozole have been developed for aromatase inhibition and are used for the treatment of breast tumors. In this paper, four 4-triazolylflavans were synthesized and were found to exhibit moderate to high inhibitory activity against aromatase.
芳香化酶是治疗雌激素依赖性癌症的药理学研究靶点。已开发出如来曲唑或阿那曲唑等唑类衍生物用于抑制芳香化酶,并用于治疗乳腺肿瘤。本文合成了四种4-三唑基黄烷,发现它们对芳香化酶表现出中度至高抑制活性。